04:25 PM EDT, 05/22/2024 (MT Newswires) -- Edward M. Kaye, Director, CEO, on May 20, 2024, sold 42,350 shares in Stoke Therapeutics ( STOK ) for $653,529. Following the Form 4 filing with the SEC, Kaye has control over a total of 27,000 shares of the company, with 27,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1623526/000141588924014087/xslF345X03/form4-05222024_080510.xml